MLN Matters Articles
MLN Matters® Articles
These Articles explain national Medicare policies on coverage, billing, and payment rules for specific provider types. Sometimes we explain information in an MLN Connects® newsletter message instead of an MLN Matters® Article. If there’s an Article or a newsletter message, you’ll find it in the “Provider Education” column.
The COVID-19 public health emergency (PHE) ended on May 11, 2023. View Infectious diseases for a list of waivers and flexibilities that were in place during the PHE.
You can filter by subject or Article number. To search all years, leave the Transmittal Year as "Any."
Displaying 8401 - 8410 of 8867
| Transmittal # | Issue Date Sort ascending | Subject | Implementation Date | CR # | Provider Education | Provider Education Release Date | Provider Education Revision Date |
|---|---|---|---|---|---|---|---|
| R45MCM | Chapter 13, Grievances Organization Determinations and Appeals |
||||||
| R145OTN | Frequent Hemodialysis Network Payment Changes for Approved Clinical Trial Costs |
3730 | |||||
| R120OTN | Override of Common Working File (CWF) Edit for Observation Services Exceeding 48 Hours |
3311 | MM3311 | ||||
| R63FM | Notice of New Interest Rate for Medicare Overpayments and Underpayments |
3454 | |||||
| R319CP | CORF/OPT Edit for Billing Inappropriate Supplies |
3468 | MM3468 | ||||
| R623CP | DMERC Only--Corrections to the Billing Indicator Field for Adjusted Claims |
3877 | |||||
| R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (… |
3191 | MM3191 | ||||
| R590CP | Aprepitant for Chemotherapy-Induced Emesis |
3831 | MM3831 | ||||
| R7ESRD | Chapter 7, Sanctions and ESRD Complaints and Grievances |
||||||
| R33NCD | Percutaneous Transluminal Angioplasty (PTA |
3811 | MM3811 |
Page Last Modified:
11/19/2024 06:23 PM